However, the binding capacity of apoE2 to LDLR was <1% of the normal value (33, 59), while apoE2-induced type III HLP only had dyslipidemia without pathological kidney changes, indicating that impaired LDLR binding abilities may not be the determining factor in kidney damage. Here, LDLR is linked to Nephropathy.